Nanosphere Appoints Chief Marketing Officer; Industry Veteran Joins As Nanosphere Prepares to Bring Protein and Nucleic Acid Detection Platform to Market

BIOWIRE2K
NORTHBROOK, Ill.--(BUSINESS WIRE)--Oct. 5, 2005--Nanosphere, Inc., a nanotechnology-based molecular diagnostics company, today announced Michael McGarrity has joined the company as chief marketing officer. McGarrity brings a wealth of marketing and business development expertise to the company at a time when it is preparing to commercialize the Verigene(R) platform for ultra-sensitive detection of proteins and nucleic acids. His skills, proven leadership and strong record of success at opening up new markets will be strong assets to Nanosphere as it increases its profile within key sectors of the molecular diagnostics and life sciences communities.

McGarrity, who has more than 17 years of sales and marketing experience in the medical device industry, joins Nanosphere after 13 years with Stryker Corporation, one of the world's leading medical device companies with products in orthopedics and other medical specialties. As vice president of marketing for Stryker Instruments, a $700 million division of $4.3 billion Stryker Corporation, McGarrity's marketing and business development acumen guided the company into markets such as post operative pain management, waste management and interventional pain management which now account for more than 20 percent of the division's revenue. Also at Stryker, he had executive general management responsibilities for creating a new division focused on interventional pain management.

“Michael McGarrity joins Nanosphere with an uncommonly strong mix of marketing and business development success”

"Michael McGarrity joins Nanosphere with an uncommonly strong mix of marketing and business development success," said William Moffitt, president and chief executive officer, Nanosphere. "During his tenure at Stryker, Michael contributed significantly to the company's more than 20-year record of increasing shareholder value. In fact, markets into which he brought the company today account for one-fifth of its revenue. We welcome Michael as a valuable addition to our management team as we move toward commercialization of our technologies and entry into various markets."

McGarrity is a graduate of the University of Notre Dame.

About Nanosphere, Inc.

Nanosphere is a life sciences company applying proprietary nanotechnology to create new standards in medical care and public safety. With a universal Verigene(R) product platform for the detection of nucleic acids and proteins at extraordinarily low concentrations, Nanosphere is rapidly advancing the development of assays for genomic and proteomic research, clinical laboratories and point-of-care markets. The privately held company is based in Northbrook, Illinois. Additional information is available at www.nanosphere-inc.com.

Contacts

Nanosphere, Inc.
Ken Bahk, Ph.D., 847-400-9000
kbahk@nanosphere.us
or
Schwartz Communications, Inc.
Jennifer Viera/Erin Walsh, 781-684-0770
nanosphere@schwartz-pr.com

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.